Alector, Inc.
ALECBiotechnology
$2.24−0.44%As of Oct 29vs prior close
- Market cap
- $250.1M
- P/E (TTM)
- –
- From 52W high
- −17.65%
- EPS (LTM)
- -$1.10
- Revenue (LTM)
- $13.9M
- Net margin
- -850.13%
- Dividend yield
- 0.00%
Nomior Score
30
Emerging BreakoutSpeculativeBottom 16% of the scored universe
Growth—
Quality25
Value38
Momentum58
Resilience27
Growth
+24.12%revenue a year over 8 fiscal years
YE17 $3.7MLTM $13.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 735% of revenue, wider by 301 pts on a year.
Who owns it
2funds